Home > Press Releases > Pharmaceutical Blister Packaging Market

Pharmaceutical Blister Packaging Market Likely to Surpass USD 34.7 Billion by 2035

Report Code: PKG-31193  |  Published in: Mar 2026, By MarketGenics  |  Number of pages: 290

Global Pharmaceutical Blister Packaging Market Forecast 2035:

According to the report, the global pharmaceutical blister packaging market is projected to expand from USD 19.2 billion in 2025 to USD 34.7 billion by 2035, registering a CAGR of 6.1%, the highest during the forecast period. The pharmaceutical blister packaging market is changing as a strategic facilitator of regulatory adherence and patient-focused medication control. As dosage accuracy, contamination control, and shelf-life preservation become increasingly important with the move to a higher-value pharmaceutical supply chain, blister formats are increasingly being enthusiastically embraced by conventional packaging types.

Manufacturers are focusing on modular and flexible design that fits the various tablet, capsule and combination therapy modes. Developments of advanced material such as barrier films and biodegradable laminates are being incorporated in order to comply with environmental standards as well as preserving the mechanical integrity during automated handling and high-speed dispensing.

Changes in the provision of healthcare in the world including direct-to-patient distribution, home-based treatment kits, and on-demand medication service are also transforming packaging demands. These models demand lightweight, tamper-evident, and small-size blister systems that can support both high-volume production as well as small-volume, customized solutions, which support the growth trend and strategic applicability of the market to the pharmaceutical ecosystem overall.

“Key Driver, Restraint, and Growth Opportunity Shaping the Global Pharmaceutical Blister Packaging Market”

The increasing trend of the use of temperature-controlled and bio-active drugs is creating a high bar pharmaceutical blister packaging requirement. Multi-layered, barrier-enhanced blisters are becoming more and more used in products that need to be kept under a controlled humidity and UV protection, as they maintain potency and shelf-life, and advanced protective packaging is becoming a vital facilitator of the quality of pharmaceuticals and patient safety.

The lack of standardization in the various regulatory systems in the globe presents a challenge to packaging producers. The fact that blister material, sealing integrity and labeling requirements can vary across regions means that they are going to be a region-specific customization, which makes it more complicated and capital-intensive to operate, especially in the small and medium-sized converters that want to be in the business of distributing their products multi-nationally.

The combination of digital monitoring and IoT-enabled blister systems are a great market opportunity. Regulatory compliance is granted by real-time temperature, humidity and handling monitoring not only, but furthermore, enables predictive maintenance, supply chain and increased patient adherence thereby allowing the value-added package solutions to be offered at high margin.  

Expansion of Global Pharmaceutical Blister Packaging Market

“Growth Driven by Drug Format Innovation and Regulatory-Grade Packaging Upgrades”  

  • The global pharmaceutical blister packaging market is steadily growing as a result of the rapid transition to oral solid dosing forms, to speciality drugs and fixed-dose combinations. Blister packaging is gaining popularity as the drugs become more complicated and interdependent in dosage, with dose accuracy, isolation of contamination, and lifecycle defence being benefits of blister packaging, structurally increasing the unit packaging requirements of branded and generic drugs.
  • Market growth is also driven by the increase of regulation enforcement in developed and emerging economies on the areas of serialization, traceability and compliance with anti-counterfeiting. Blisters are becoming compliance-enabled packages due to the combination of track-and-trace coding, tamper-evident blister formats, and patient-level authentication capabilities, and their value as per-unit packaging is skyrocketing, as well as technology penetration.

Regional Analysis of Global Pharmaceutical Blister Packaging Market

  • Asia Pacific has dominated the global pharmaceuticals blister packaging market because there is concentration of pharmaceutical manufacturing centers, extensive generic drug production, and blister pharmaceutical contract packaging activities. Constant investments in high speed thermoforming lines, low-cost PVC/PVDC capacity, and export-compliant upgrades are supporting the existing volume leadership and price competitive supply benefits of the region.
  • North America is the most promising pharmaceutical blister pack market, which is propelled by increasing rates of specialty drug adoption, increasing volumes of unit-dose packaging, and a steep rate of clinical trial packaging. The movement to new high-tech smart blister systems, child resistant forms and high barrier cold-form materials is driving a rapid value-based growth in regulated prescription and OTC market segments.

Prominent players operating in the global pharmaceutical blister packaging market are ACG Worldwide, Algus Packaging Inc., Amcor plc, Bausch + Ströbel, Bilcare Limited, Constantia Flexibles Group, Gerresheimer AG, Honeywell International Inc., IMA Group, Klöckner Pentaplast, Körber AG, Marchesini Group S.p.A., Multivac Group, Nipro Corporation, Pharma Packaging Solutions, Rollprint Packaging Products, Romaco Group, Schott AG, Sonoco Products Company, Tekni-Plex, Uhlmann Pac-Systeme GmbH & Co. KG, WestRock Company, and Other Key Players.     

The global pharmaceutical blister packaging market has been segmented as follows:

Global Pharmaceutical Blister Packaging Market Analysis, By Material Type

  • Plastic Films
    • PVC (Polyvinyl Chloride)
    • PVDC (Polyvinylidene Chloride)
    • Aclar (PCTFE)
    • PET (Polyethylene Terephthalate)
    • PE (Polyethylene)
    • PP (Polypropylene)
    • Others
  • Aluminum Foil
    • Push-through Aluminum Foil
    • Child-resistant Aluminum Foil
    • Tropical Aluminum Foil
    • Others
  • Paper & Paperboard
  • Other Material Type

Global Pharmaceutical Blister Packaging Market Analysis, By Product Type

  • Carded Blister
  • Clamshell Blister
  • Slide Blister
  • Mock Clamshell
  • Trapped Blister
  • Face Seal Blister
  • Others

Global Pharmaceutical Blister Packaging Market Analysis, By Technology/Process Type

  • Thermoforming
  • Cold Forming
  • Controlled Atmospheric Packaging
  • Others

Global Pharmaceutical Blister Packaging Market Analysis, By Machine Type

  • Rotary Blister Packaging Machines
  • Flat-Bed Blister Packaging Machines
  • Continuous Motion Machines
  • Intermittent Motion Machines
  • Others

Global Pharmaceutical Blister Packaging Market Analysis, By Rated Capacity (Blisters per Minute)

  • Below 100 BPM
  • 100-300 BPM
  • 300-600 BPM
  • Above 600 BPM

Global Pharmaceutical Blister Packaging Market Analysis, By Pack Size

  • Single-dose Blister
  • Multi-dose Blister
    • 7 Count
    • 10 Count
    • Custom Count

Global Pharmaceutical Blister Packaging Market Analysis, By Blister Configuration

  • Single Cavity
  • Multi-Cavity
  • Unit Dose
  • Compliance Packaging
  • Peelable Blister

Global Pharmaceutical Blister Packaging Market Analysis, By Drug Form

  • Tablets & Capsules
  • Lozenges
  • Medical Devices
  • Suppositories
  • Ampoules/Vials
  • Others

Global Pharmaceutical Blister Packaging Market Analysis, By Distribution Channel

  • Direct Sales
  • Distributors
  • Online Channels

Global Pharmaceutical Blister Packaging Market Analysis, By End-use Applications

  • Pharmaceutical Manufacturing Companies
    • Prescription Drugs Packaging
    • Over-the-Counter (OTC) Drugs Packaging
    • Generic Drugs Packaging
    • Branded Drugs Packaging
    • Veterinary Drugs Packaging
    • Others
  • Contract Packaging Organizations
    • Clinical Trial Packaging
    • Commercial Packaging Services
    • Re-packaging Services
    • Serialization Services
    • Temperature-controlled Packaging
    • Others
  • Hospital & Retail Pharmacies
    • Unit Dose Packaging
    • Patient-specific Packaging
    • Compliance Packaging
    • Dispensing Packaging
    • Institutional Packaging
    • Others
  • Nutraceutical & Dietary Supplement Manufacturers
    • Vitamin Packaging
    • Mineral Supplement Packaging
    • Herbal Supplement Packaging
    • Probiotic Packaging
    • Sports Nutrition Packaging
    • Others
  • Biotechnology Companies
    • Biologic Drugs Packaging
    • Biosimilar Packaging
    • Specialty Therapeutics Packaging
    • Personalized Medicine Packaging
    • Others
  • Medical Device Manufacturers
    • Surgical Instrument Packaging
    • Diagnostic Device Packaging
    • Implantable Device Packaging
    • Disposable Medical Device Packaging
    • Others

Global Pharmaceutical Blister Packaging Market Analysis, By Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • South America

About Us

MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.

Contact Us

USA Address:

800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.

+1(302)303-2617

info@marketgenics.co

India Address:

3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.

sales@marketgenics.co

Table of Contents

  • 1. Research Methodology and Assumptions
    • 1.1. Definitions
    • 1.2. Research Design and Approach
    • 1.3. Data Collection Methods
    • 1.4. Base Estimates and Calculations
    • 1.5. Forecasting Models
      • 1.5.1. Key Forecast Factors & Impact Analysis
    • 1.6. Secondary Research
      • 1.6.1. Open Sources
      • 1.6.2. Paid Databases
      • 1.6.3. Associations
    • 1.7. Primary Research
      • 1.7.1. Primary Sources
      • 1.7.2. Primary Interviews with Stakeholders across Ecosystem
  • 2. Executive Summary
    • 2.1. Global Pharmaceutical Blister Packaging Market Outlook
      • 2.1.1. Pharmaceutical Blister Packaging Market Size Value (US$ Bn), and Forecasts, 2021-2035
      • 2.1.2. Compounded Annual Growth Rate Analysis
      • 2.1.3. Growth Opportunity Analysis
      • 2.1.4. Segmental Share Analysis
      • 2.1.5. Geographical Share Analysis
    • 2.2. Market Analysis and Facts
    • 2.3. Supply-Demand Analysis
    • 2.4. Competitive Benchmarking
    • 2.5. Go-to- Market Strategy
      • 2.5.1. Customer/ End-use Industry Assessment
      • 2.5.2. Growth Opportunity Data, 2026-2035
        • 2.5.2.1. Regional Data
        • 2.5.2.2. Country Data
        • 2.5.2.3. Segmental Data
      • 2.5.3. Identification of Potential Market Spaces
      • 2.5.4. GAP Analysis
      • 2.5.5. Potential Attractive Price Points
      • 2.5.6. Prevailing Market Risks & Challenges
      • 2.5.7. Preferred Sales & Marketing Strategies
      • 2.5.8. Key Recommendations and Analysis
      • 2.5.9. A Way Forward
  • 3. Industry Data and Premium Insights
    • 3.1. Global Packaging Industry Overview, 2025
      • 3.1.1. Packaging Industry Ecosystem Analysis
      • 3.1.2. Key Trends for Packaging Industry
      • 3.1.3. Regional Distribution for Packaging Industry
    • 3.2. Supplier Customer Data
    • 3.3. Technology Roadmap and Developments
    • 3.4. Trade Analysis
      • 3.4.1. Import & Export Analysis, 2025
      • 3.4.2. Top Importing Countries
      • 3.4.3. Top Exporting Countries
    • 3.5. Trump Tariff Impact Analysis
      • 3.5.1. Manufacturer
        • 3.5.1.1. Based on the component & Raw material
      • 3.5.2. Supply Chain
      • 3.5.3. End Consumer
    • 3.6. Raw Material Analysis
  • 4. Market Overview
    • 4.1. Market Dynamics
      • 4.1.1. Drivers
        • 4.1.1.1. Growing demand for oral solid-dose medicines and rising chronic disease burden.
        • 4.1.1.2. Stringent regulatory/safety requirements (tamper-evidence, serialization, dose accuracy).
        • 4.1.1.3. Technological advances (automated blistering, high-barrier films, smart/serialized packaging).
      • 4.1.2. Restraints
        • 4.1.2.1. High capital expenditure for blistering lines, tooling and validation.
        • 4.1.2.2. Environmental concerns and shift toward sustainable/flexible packaging alternatives.
    • 4.2. Key Trend Analysis
    • 4.3. Regulatory Framework
      • 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
      • 4.3.2. Tariffs and Standards
      • 4.3.3. Impact Analysis of Regulations on the Market
    • 4.4. Value Chain Analysis
      • 4.4.1. Raw Material Suppliers
      • 4.4.2. Manufacturing
      • 4.4.3. Distribution
      • 4.4.4. End-Use
    • 4.5. Porter’s Five Forces Analysis
    • 4.6. PESTEL Analysis
    • 4.7. Global Pharmaceutical Blister Packaging Market Demand
      • 4.7.1. Historical Market Size – Value (US$ Bn), 2020-2024
      • 4.7.2. Current and Future Market Size – Value (US$ Bn), 2026–2035
        • 4.7.2.1. Y-o-Y Growth Trends
        • 4.7.2.2. Absolute $ Opportunity Assessment
  • 5. Competition Landscape
    • 5.1. Competition structure
      • 5.1.1. Fragmented v/s consolidated
    • 5.2. Company Share Analysis, 2025
      • 5.2.1. Global Company Market Share
      • 5.2.2. By Region
        • 5.2.2.1. North America
        • 5.2.2.2. Europe
        • 5.2.2.3. Asia Pacific
        • 5.2.2.4. Middle East
        • 5.2.2.5. Africa
        • 5.2.2.6. South America
    • 5.3. Product Comparison Matrix
      • 5.3.1. Specifications
      • 5.3.2. Market Positioning
      • 5.3.3. Pricing
  • 6. Global Pharmaceutical Blister Packaging Market Analysis, by Material Type
    • 6.1. Key Segment Analysis
    • 6.2. Pharmaceutical Blister Packaging Market Size Value (US$ Bn), Analysis, and Forecasts, by Material Type, 2021-2035
      • 6.2.1. Plastic Films
        • 6.2.1.1. PVC (Polyvinyl Chloride)
        • 6.2.1.2. PVDC (Polyvinylidene Chloride)
        • 6.2.1.3. Aclar (PCTFE)
        • 6.2.1.4. PET (Polyethylene Terephthalate)
        • 6.2.1.5. PE (Polyethylene)
        • 6.2.1.6. PP (Polypropylene)
        • 6.2.1.7. Others
      • 6.2.2. Aluminum Foil
        • 6.2.2.1. Push-through Aluminum Foil
        • 6.2.2.2. Child-resistant Aluminum Foil
        • 6.2.2.3. Tropical Aluminum Foil
        • 6.2.2.4. Others
      • 6.2.3. Paper & Paperboard
      • 6.2.4. Other Material Type
  • 7. Global Pharmaceutical Blister Packaging Market Analysis, by Product Type
    • 7.1. Key Segment Analysis
    • 7.2. Pharmaceutical Blister Packaging Market Size Value (US$ Bn), Analysis, and Forecasts, by Product Type, 2021-2035
      • 7.2.1. Carded Blister
      • 7.2.2. Clamshell Blister
      • 7.2.3. Slide Blister
      • 7.2.4. Mock Clamshell
      • 7.2.5. Trapped Blister
      • 7.2.6. Face Seal Blister
      • 7.2.7. Others
  • 8. Global Pharmaceutical Blister Packaging Market Analysis, by Technology/Process Type
    • 8.1. Key Segment Analysis
    • 8.2. Pharmaceutical Blister Packaging Market Size Value (US$ Bn), Analysis, and Forecasts, by Technology/Process Type, 2021-2035
      • 8.2.1. Thermoforming
      • 8.2.2. Cold Forming
      • 8.2.3. Controlled Atmospheric Packaging
      • 8.2.4. Others
  • 9. Global Pharmaceutical Blister Packaging Market Analysis, by Machine Type
    • 9.1. Key Segment Analysis
    • 9.2. Pharmaceutical Blister Packaging Market Size Value (US$ Bn), Analysis, and Forecasts, by Machine Type, 2021-2035
      • 9.2.1. Rotary Blister Packaging Machines
      • 9.2.2. Flat-Bed Blister Packaging Machines
      • 9.2.3. Continuous Motion Machines
      • 9.2.4. Intermittent Motion Machines
      • 9.2.5. Others
  • 10. Global Pharmaceutical Blister Packaging Market Analysis, by Rated Capacity (Blisters per Minute)
    • 10.1. Key Segment Analysis
    • 10.2. Pharmaceutical Blister Packaging Market Size Value (US$ Bn), Analysis, and Forecasts, by Rated Capacity (Blisters per Minute), 2021-2035
      • 10.2.1. Below 100 BPM
      • 10.2.2. 100-300 BPM
      • 10.2.3. 300-600 BPM
      • 10.2.4. Above 600 BPM
  • 11. Global Pharmaceutical Blister Packaging Market Analysis, by Pack Size
    • 11.1. Key Segment Analysis
    • 11.2. Pharmaceutical Blister Packaging Market Size Value (US$ Bn), Analysis, and Forecasts, by Pack Size, 2021-2035
      • 11.2.1. Single-dose Blister
      • 11.2.2. Multi-dose Blister
        • 11.2.2.1. 7 Count
        • 11.2.2.2. 10 Count
        • 11.2.2.3. Custom Count
  • 12. Global Pharmaceutical Blister Packaging Market Analysis, by Blister Configuration
    • 12.1. Key Segment Analysis
    • 12.2. Pharmaceutical Blister Packaging Market Size Value (US$ Bn), Analysis, and Forecasts, by Blister Configuration, 2021-2035
      • 12.2.1. Single Cavity
      • 12.2.2. Multi-Cavity
      • 12.2.3. Unit Dose
      • 12.2.4. Compliance Packaging
      • 12.2.5. Peelable Blister
  • 13. Global Pharmaceutical Blister Packaging Market Analysis, by Drug Form
    • 13.1. Key Segment Analysis
    • 13.2. Pharmaceutical Blister Packaging Market Size Value (US$ Bn), Analysis, and Forecasts, by Drug Form, 2021-2035
      • 13.2.1. Tablets & Capsules
      • 13.2.2. Lozenges
      • 13.2.3. Medical Devices
      • 13.2.4. Suppositories
      • 13.2.5. Ampoules/Vials
      • 13.2.6. Others
  • 14. Global Pharmaceutical Blister Packaging Market Analysis, by Distribution Channel
    • 14.1. Key Segment Analysis
    • 14.2. Pharmaceutical Blister Packaging Market Size Value (US$ Bn), Analysis, and Forecasts, by Distribution Channel, 2021-2035
      • 14.2.1. Direct Sales
      • 14.2.2. Distributors
      • 14.2.3. Online Channels
  • 15. Global Pharmaceutical Blister Packaging Market Analysis, by End-use Applications
    • 15.1. Key Segment Analysis
    • 15.2. Pharmaceutical Blister Packaging Market Size Value (US$ Bn), Analysis, and Forecasts, by End-use Applications, 2021-2035
      • 15.2.1. Pharmaceutical Manufacturing Companies
        • 15.2.1.1. Prescription Drugs Packaging
        • 15.2.1.2. Over-the-Counter (OTC) Drugs Packaging
        • 15.2.1.3. Generic Drugs Packaging
        • 15.2.1.4. Branded Drugs Packaging
        • 15.2.1.5. Veterinary Drugs Packaging
        • 15.2.1.6. Others
      • 15.2.2. Contract Packaging Organizations
        • 15.2.2.1. Clinical Trial Packaging
        • 15.2.2.2. Commercial Packaging Services
        • 15.2.2.3. Re-packaging Services
        • 15.2.2.4. Serialization Services
        • 15.2.2.5. Temperature-controlled Packaging
        • 15.2.2.6. Others
      • 15.2.3. Hospital & Retail Pharmacies
        • 15.2.3.1. Unit Dose Packaging
        • 15.2.3.2. Patient-specific Packaging
        • 15.2.3.3. Compliance Packaging
        • 15.2.3.4. Dispensing Packaging
        • 15.2.3.5. Institutional Packaging
        • 15.2.3.6. Others
      • 15.2.4. Nutraceutical & Dietary Supplement Manufacturers
        • 15.2.4.1. Vitamin Packaging
        • 15.2.4.2. Mineral Supplement Packaging
        • 15.2.4.3. Herbal Supplement Packaging
        • 15.2.4.4. Probiotic Packaging
        • 15.2.4.5. Sports Nutrition Packaging
        • 15.2.4.6. Others
      • 15.2.5. Biotechnology Companies
        • 15.2.5.1. Biologic Drugs Packaging
        • 15.2.5.2. Biosimilar Packaging
        • 15.2.5.3. Specialty Therapeutics Packaging
        • 15.2.5.4. Personalized Medicine Packaging
        • 15.2.5.5. Others
      • 15.2.6. Medical Device Manufacturers
        • 15.2.6.1. Surgical Instrument Packaging
        • 15.2.6.2. Diagnostic Device Packaging
        • 15.2.6.3. Implantable Device Packaging
        • 15.2.6.4. Disposable Medical Device Packaging
        • 15.2.6.5. Others
  • 16. Global Pharmaceutical Blister Packaging Market Analysis and Forecasts, by Region
    • 16.1. Key Findings
    • 16.2. Pharmaceutical Blister Packaging Market Size Value (US$ Bn), Analysis, and Forecasts, by Region, 2021-2035
      • 16.2.1. North America
      • 16.2.2. Europe
      • 16.2.3. Asia Pacific
      • 16.2.4. Middle East
      • 16.2.5. Africa
      • 16.2.6. South America
  • 17. North America Pharmaceutical Blister Packaging Market Analysis
    • 17.1. Key Segment Analysis
    • 17.2. Regional Snapshot
    • 17.3. North America Pharmaceutical Blister Packaging Market Size- Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 17.3.1. Material Type
      • 17.3.2. Product Type
      • 17.3.3. Technology/Process Type
      • 17.3.4. Machine Type
      • 17.3.5. Pack Size
      • 17.3.6. Blister Configuration
      • 17.3.7. Drug Form
      • 17.3.8. Distribution Channel
      • 17.3.9. End-use Applications
      • 17.3.10. Country
        • 17.3.10.1. USA
        • 17.3.10.2. Canada
        • 17.3.10.3. Mexico
    • 17.4. USA Pharmaceutical Blister Packaging Market
      • 17.4.1. Country Segmental Analysis
      • 17.4.2. Material Type
      • 17.4.3. Product Type
      • 17.4.4. Technology/Process Type
      • 17.4.5. Machine Type
      • 17.4.6. Pack Size
      • 17.4.7. Blister Configuration
      • 17.4.8. Drug Form
      • 17.4.9. Distribution Channel
      • 17.4.10. End-use Applications
    • 17.5. Canada Pharmaceutical Blister Packaging Market
      • 17.5.1. Country Segmental Analysis
      • 17.5.2. Material Type
      • 17.5.3. Product Type
      • 17.5.4. Technology/Process Type
      • 17.5.5. Machine Type
      • 17.5.6. Pack Size
      • 17.5.7. Blister Configuration
      • 17.5.8. Drug Form
      • 17.5.9. Distribution Channel
      • 17.5.10. End-use Applications
    • 17.6. Mexico Pharmaceutical Blister Packaging Market
      • 17.6.1. Country Segmental Analysis
      • 17.6.2. Material Type
      • 17.6.3. Product Type
      • 17.6.4. Technology/Process Type
      • 17.6.5. Machine Type
      • 17.6.6. Pack Size
      • 17.6.7. Blister Configuration
      • 17.6.8. Drug Form
      • 17.6.9. Distribution Channel
      • 17.6.10. End-use Applications
  • 18. Europe Pharmaceutical Blister Packaging Market Analysis
    • 18.1. Key Segment Analysis
    • 18.2. Regional Snapshot
    • 18.3. Europe Pharmaceutical Blister Packaging Market Size Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 18.3.1. Material Type
      • 18.3.2. Product Type
      • 18.3.3. Technology/Process Type
      • 18.3.4. Machine Type
      • 18.3.5. Pack Size
      • 18.3.6. Blister Configuration
      • 18.3.7. Drug Form
      • 18.3.8. Distribution Channel
      • 18.3.9. End-use Applications
      • 18.3.10. Country
        • 18.3.10.1. Germany
        • 18.3.10.2. United Kingdom
        • 18.3.10.3. France
        • 18.3.10.4. Italy
        • 18.3.10.5. Spain
        • 18.3.10.6. Netherlands
        • 18.3.10.7. Nordic Countries
        • 18.3.10.8. Poland
        • 18.3.10.9. Russia & CIS
        • 18.3.10.10. Rest of Europe
    • 18.4. Germany Pharmaceutical Blister Packaging Market
      • 18.4.1. Country Segmental Analysis
      • 18.4.2. Material Type
      • 18.4.3. Product Type
      • 18.4.4. Technology/Process Type
      • 18.4.5. Machine Type
      • 18.4.6. Pack Size
      • 18.4.7. Blister Configuration
      • 18.4.8. Drug Form
      • 18.4.9. Distribution Channel
      • 18.4.10. End-use Applications
    • 18.5. United Kingdom Pharmaceutical Blister Packaging Market
      • 18.5.1. Country Segmental Analysis
      • 18.5.2. Material Type
      • 18.5.3. Product Type
      • 18.5.4. Technology/Process Type
      • 18.5.5. Machine Type
      • 18.5.6. Pack Size
      • 18.5.7. Blister Configuration
      • 18.5.8. Drug Form
      • 18.5.9. Distribution Channel
      • 18.5.10. End-use Applications
    • 18.6. France Pharmaceutical Blister Packaging Market
      • 18.6.1. Country Segmental Analysis
      • 18.6.2. Material Type
      • 18.6.3. Product Type
      • 18.6.4. Technology/Process Type
      • 18.6.5. Machine Type
      • 18.6.6. Pack Size
      • 18.6.7. Blister Configuration
      • 18.6.8. Drug Form
      • 18.6.9. Distribution Channel
      • 18.6.10. End-use Applications
    • 18.7. Italy Pharmaceutical Blister Packaging Market
      • 18.7.1. Country Segmental Analysis
      • 18.7.2. Material Type
      • 18.7.3. Product Type
      • 18.7.4. Technology/Process Type
      • 18.7.5. Machine Type
      • 18.7.6. Pack Size
      • 18.7.7. Blister Configuration
      • 18.7.8. Drug Form
      • 18.7.9. Distribution Channel
      • 18.7.10. End-use Applications
    • 18.8. Spain Pharmaceutical Blister Packaging Market
      • 18.8.1. Country Segmental Analysis
      • 18.8.2. Material Type
      • 18.8.3. Product Type
      • 18.8.4. Technology/Process Type
      • 18.8.5. Machine Type
      • 18.8.6. Pack Size
      • 18.8.7. Blister Configuration
      • 18.8.8. Drug Form
      • 18.8.9. Distribution Channel
      • 18.8.10. End-use Applications
    • 18.9. Netherlands Pharmaceutical Blister Packaging Market
      • 18.9.1. Country Segmental Analysis
      • 18.9.2. Material Type
      • 18.9.3. Product Type
      • 18.9.4. Technology/Process Type
      • 18.9.5. Machine Type
      • 18.9.6. Pack Size
      • 18.9.7. Blister Configuration
      • 18.9.8. Drug Form
      • 18.9.9. Distribution Channel
      • 18.9.10. End-use Applications
    • 18.10. Nordic Countries Pharmaceutical Blister Packaging Market
      • 18.10.1. Country Segmental Analysis
      • 18.10.2. Material Type
      • 18.10.3. Product Type
      • 18.10.4. Technology/Process Type
      • 18.10.5. Machine Type
      • 18.10.6. Pack Size
      • 18.10.7. Blister Configuration
      • 18.10.8. Drug Form
      • 18.10.9. Distribution Channel
      • 18.10.10. End-use Applications
    • 18.11. Poland Pharmaceutical Blister Packaging Market
      • 18.11.1. Country Segmental Analysis
      • 18.11.2. Material Type
      • 18.11.3. Product Type
      • 18.11.4. Technology/Process Type
      • 18.11.5. Machine Type
      • 18.11.6. Pack Size
      • 18.11.7. Blister Configuration
      • 18.11.8. Drug Form
      • 18.11.9. Distribution Channel
      • 18.11.10. End-use Applications
    • 18.12. Russia & CIS Pharmaceutical Blister Packaging Market
      • 18.12.1. Country Segmental Analysis
      • 18.12.2. Material Type
      • 18.12.3. Product Type
      • 18.12.4. Technology/Process Type
      • 18.12.5. Machine Type
      • 18.12.6. Pack Size
      • 18.12.7. Blister Configuration
      • 18.12.8. Drug Form
      • 18.12.9. Distribution Channel
      • 18.12.10. End-use Applications
    • 18.13. Rest of Europe Pharmaceutical Blister Packaging Market
      • 18.13.1. Country Segmental Analysis
      • 18.13.2. Material Type
      • 18.13.3. Product Type
      • 18.13.4. Technology/Process Type
      • 18.13.5. Machine Type
      • 18.13.6. Pack Size
      • 18.13.7. Blister Configuration
      • 18.13.8. Drug Form
      • 18.13.9. Distribution Channel
      • 18.13.10. End-use Applications
  • 19. Asia Pacific Pharmaceutical Blister Packaging Market Analysis
    • 19.1. Key Segment Analysis
    • 19.2. Regional Snapshot
    • 19.3. Asia Pacific Pharmaceutical Blister Packaging Market Size Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 19.3.1. Material Type
      • 19.3.2. Product Type
      • 19.3.3. Technology/Process Type
      • 19.3.4. Machine Type
      • 19.3.5. Pack Size
      • 19.3.6. Blister Configuration
      • 19.3.7. Drug Form
      • 19.3.8. Distribution Channel
      • 19.3.9. End-use Applications
      • 19.3.10. Country
        • 19.3.10.1. China
        • 19.3.10.2. India
        • 19.3.10.3. Japan
        • 19.3.10.4. South Korea
        • 19.3.10.5. Australia and New Zealand
        • 19.3.10.6. Indonesia
        • 19.3.10.7. Malaysia
        • 19.3.10.8. Thailand
        • 19.3.10.9. Vietnam
        • 19.3.10.10. Rest of Asia Pacific
    • 19.4. China Pharmaceutical Blister Packaging Market
      • 19.4.1. Country Segmental Analysis
      • 19.4.2. Material Type
      • 19.4.3. Product Type
      • 19.4.4. Technology/Process Type
      • 19.4.5. Machine Type
      • 19.4.6. Pack Size
      • 19.4.7. Blister Configuration
      • 19.4.8. Drug Form
      • 19.4.9. Distribution Channel
      • 19.4.10. End-use Applications
    • 19.5. India Pharmaceutical Blister Packaging Market
      • 19.5.1. Country Segmental Analysis
      • 19.5.2. Material Type
      • 19.5.3. Product Type
      • 19.5.4. Technology/Process Type
      • 19.5.5. Machine Type
      • 19.5.6. Pack Size
      • 19.5.7. Blister Configuration
      • 19.5.8. Drug Form
      • 19.5.9. Distribution Channel
      • 19.5.10. End-use Applications
    • 19.6. Japan Pharmaceutical Blister Packaging Market
      • 19.6.1. Country Segmental Analysis
      • 19.6.2. Material Type
      • 19.6.3. Product Type
      • 19.6.4. Technology/Process Type
      • 19.6.5. Machine Type
      • 19.6.6. Pack Size
      • 19.6.7. Blister Configuration
      • 19.6.8. Drug Form
      • 19.6.9. Distribution Channel
      • 19.6.10. End-use Applications
    • 19.7. South Korea Pharmaceutical Blister Packaging Market
      • 19.7.1. Country Segmental Analysis
      • 19.7.2. Material Type
      • 19.7.3. Product Type
      • 19.7.4. Technology/Process Type
      • 19.7.5. Machine Type
      • 19.7.6. Pack Size
      • 19.7.7. Blister Configuration
      • 19.7.8. Drug Form
      • 19.7.9. Distribution Channel
      • 19.7.10. End-use Applications
    • 19.8. Australia and New Zealand Pharmaceutical Blister Packaging Market
      • 19.8.1. Country Segmental Analysis
      • 19.8.2. Material Type
      • 19.8.3. Product Type
      • 19.8.4. Technology/Process Type
      • 19.8.5. Machine Type
      • 19.8.6. Pack Size
      • 19.8.7. Blister Configuration
      • 19.8.8. Drug Form
      • 19.8.9. Distribution Channel
      • 19.8.10. End-use Applications
    • 19.9. Indonesia Pharmaceutical Blister Packaging Market
      • 19.9.1. Country Segmental Analysis
      • 19.9.2. Material Type
      • 19.9.3. Product Type
      • 19.9.4. Technology/Process Type
      • 19.9.5. Machine Type
      • 19.9.6. Pack Size
      • 19.9.7. Blister Configuration
      • 19.9.8. Drug Form
      • 19.9.9. Distribution Channel
      • 19.9.10. End-use Applications
    • 19.10. Malaysia Pharmaceutical Blister Packaging Market
      • 19.10.1. Country Segmental Analysis
      • 19.10.2. Material Type
      • 19.10.3. Product Type
      • 19.10.4. Technology/Process Type
      • 19.10.5. Machine Type
      • 19.10.6. Pack Size
      • 19.10.7. Blister Configuration
      • 19.10.8. Drug Form
      • 19.10.9. Distribution Channel
      • 19.10.10. End-use Applications
    • 19.11. Thailand Pharmaceutical Blister Packaging Market
      • 19.11.1. Country Segmental Analysis
      • 19.11.2. Material Type
      • 19.11.3. Product Type
      • 19.11.4. Technology/Process Type
      • 19.11.5. Machine Type
      • 19.11.6. Pack Size
      • 19.11.7. Blister Configuration
      • 19.11.8. Drug Form
      • 19.11.9. Distribution Channel
      • 19.11.10. End-use Applications
    • 19.12. Vietnam Pharmaceutical Blister Packaging Market
      • 19.12.1. Country Segmental Analysis
      • 19.12.2. Material Type
      • 19.12.3. Product Type
      • 19.12.4. Technology/Process Type
      • 19.12.5. Machine Type
      • 19.12.6. Pack Size
      • 19.12.7. Blister Configuration
      • 19.12.8. Drug Form
      • 19.12.9. Distribution Channel
      • 19.12.10. End-use Applications
    • 19.13. Rest of Asia Pacific Pharmaceutical Blister Packaging Market
      • 19.13.1. Country Segmental Analysis
      • 19.13.2. Material Type
      • 19.13.3. Product Type
      • 19.13.4. Technology/Process Type
      • 19.13.5. Machine Type
      • 19.13.6. Pack Size
      • 19.13.7. Blister Configuration
      • 19.13.8. Drug Form
      • 19.13.9. Distribution Channel
      • 19.13.10. End-use Applications
  • 20. Middle East Pharmaceutical Blister Packaging Market Analysis
    • 20.1. Key Segment Analysis
    • 20.2. Regional Snapshot
    • 20.3. Middle East Pharmaceutical Blister Packaging Market Size Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 20.3.1. Material Type
      • 20.3.2. Product Type
      • 20.3.3. Technology/Process Type
      • 20.3.4. Machine Type
      • 20.3.5. Pack Size
      • 20.3.6. Blister Configuration
      • 20.3.7. Drug Form
      • 20.3.8. Distribution Channel
      • 20.3.9. End-use Applications
      • 20.3.10. Country
        • 20.3.10.1. Turkey
        • 20.3.10.2. UAE
        • 20.3.10.3. Saudi Arabia
        • 20.3.10.4. Israel
        • 20.3.10.5. Rest of Middle East
    • 20.4. Turkey Pharmaceutical Blister Packaging Market
      • 20.4.1. Country Segmental Analysis
      • 20.4.2. Material Type
      • 20.4.3. Product Type
      • 20.4.4. Technology/Process Type
      • 20.4.5. Machine Type
      • 20.4.6. Pack Size
      • 20.4.7. Blister Configuration
      • 20.4.8. Drug Form
      • 20.4.9. Distribution Channel
      • 20.4.10. End-use Applications
    • 20.5. UAE Pharmaceutical Blister Packaging Market
      • 20.5.1. Country Segmental Analysis
      • 20.5.2. Material Type
      • 20.5.3. Product Type
      • 20.5.4. Technology/Process Type
      • 20.5.5. Machine Type
      • 20.5.6. Pack Size
      • 20.5.7. Blister Configuration
      • 20.5.8. Drug Form
      • 20.5.9. Distribution Channel
      • 20.5.10. End-use Applications
    • 20.6. Saudi Arabia Pharmaceutical Blister Packaging Market
      • 20.6.1. Country Segmental Analysis
      • 20.6.2. Material Type
      • 20.6.3. Product Type
      • 20.6.4. Technology/Process Type
      • 20.6.5. Machine Type
      • 20.6.6. Pack Size
      • 20.6.7. Blister Configuration
      • 20.6.8. Drug Form
      • 20.6.9. Distribution Channel
      • 20.6.10. End-use Applications
    • 20.7. Israel Pharmaceutical Blister Packaging Market
      • 20.7.1. Country Segmental Analysis
      • 20.7.2. Material Type
      • 20.7.3. Product Type
      • 20.7.4. Technology/Process Type
      • 20.7.5. Machine Type
      • 20.7.6. Pack Size
      • 20.7.7. Blister Configuration
      • 20.7.8. Drug Form
      • 20.7.9. Distribution Channel
      • 20.7.10. End-use Applications
    • 20.8. Rest of Middle East Pharmaceutical Blister Packaging Market
      • 20.8.1. Country Segmental Analysis
      • 20.8.2. Material Type
      • 20.8.3. Product Type
      • 20.8.4. Technology/Process Type
      • 20.8.5. Machine Type
      • 20.8.6. Pack Size
      • 20.8.7. Blister Configuration
      • 20.8.8. Drug Form
      • 20.8.9. Distribution Channel
      • 20.8.10. End-use Applications
  • 21. Africa Pharmaceutical Blister Packaging Market Analysis
    • 21.1. Key Segment Analysis
    • 21.2. Regional Snapshot
    • 21.3. Africa Pharmaceutical Blister Packaging Market Size Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 21.3.1. Material Type
      • 21.3.2. Product Type
      • 21.3.3. Technology/Process Type
      • 21.3.4. Machine Type
      • 21.3.5. Pack Size
      • 21.3.6. Blister Configuration
      • 21.3.7. Drug Form
      • 21.3.8. Distribution Channel
      • 21.3.9. End-use Applications
        • 21.3.9.1. South Africa
        • 21.3.9.2. Egypt
        • 21.3.9.3. Nigeria
        • 21.3.9.4. Algeria
        • 21.3.9.5. Rest of Africa
    • 21.4. South Africa Pharmaceutical Blister Packaging Market
      • 21.4.1. Country Segmental Analysis
      • 21.4.2. Material Type
      • 21.4.3. Product Type
      • 21.4.4. Technology/Process Type
      • 21.4.5. Machine Type
      • 21.4.6. Pack Size
      • 21.4.7. Blister Configuration
      • 21.4.8. Drug Form
      • 21.4.9. Distribution Channel
      • 21.4.10. End-use Applications
    • 21.5. Egypt Pharmaceutical Blister Packaging Market
      • 21.5.1. Country Segmental Analysis
      • 21.5.2. Material Type
      • 21.5.3. Product Type
      • 21.5.4. Technology/Process Type
      • 21.5.5. Machine Type
      • 21.5.6. Pack Size
      • 21.5.7. Blister Configuration
      • 21.5.8. Drug Form
      • 21.5.9. Distribution Channel
      • 21.5.10. End-use Applications
    • 21.6. Nigeria Pharmaceutical Blister Packaging Market
      • 21.6.1. Country Segmental Analysis
      • 21.6.2. Material Type
      • 21.6.3. Product Type
      • 21.6.4. Technology/Process Type
      • 21.6.5. Machine Type
      • 21.6.6. Pack Size
      • 21.6.7. Blister Configuration
      • 21.6.8. Drug Form
      • 21.6.9. Distribution Channel
      • 21.6.10. End-use Applications
    • 21.7. Algeria Pharmaceutical Blister Packaging Market
      • 21.7.1. Country Segmental Analysis
      • 21.7.2. Material Type
      • 21.7.3. Product Type
      • 21.7.4. Technology/Process Type
      • 21.7.5. Machine Type
      • 21.7.6. Pack Size
      • 21.7.7. Blister Configuration
      • 21.7.8. Drug Form
      • 21.7.9. Distribution Channel
      • 21.7.10. End-use Applications
    • 21.8. Rest of Africa Pharmaceutical Blister Packaging Market
      • 21.8.1. Country Segmental Analysis
      • 21.8.2. Material Type
      • 21.8.3. Product Type
      • 21.8.4. Technology/Process Type
      • 21.8.5. Machine Type
      • 21.8.6. Pack Size
      • 21.8.7. Blister Configuration
      • 21.8.8. Drug Form
      • 21.8.9. Distribution Channel
      • 21.8.10. End-use Applications
  • 22. South America Pharmaceutical Blister Packaging Market Analysis
    • 22.1. Key Segment Analysis
    • 22.2. Regional Snapshot
    • 22.3. South America Pharmaceutical Blister Packaging Market Size Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 22.3.1. Material Type
      • 22.3.2. Product Type
      • 22.3.3. Technology/Process Type
      • 22.3.4. Machine Type
      • 22.3.5. Pack Size
      • 22.3.6. Blister Configuration
      • 22.3.7. Drug Form
      • 22.3.8. Distribution Channel
      • 22.3.9. End-use Applications
      • 22.3.10. Country
        • 22.3.10.1. Brazil
        • 22.3.10.2. Argentina
        • 22.3.10.3. Rest of South America
    • 22.4. Brazil Pharmaceutical Blister Packaging Market
      • 22.4.1. Country Segmental Analysis
      • 22.4.2. Material Type
      • 22.4.3. Product Type
      • 22.4.4. Technology/Process Type
      • 22.4.5. Machine Type
      • 22.4.6. Pack Size
      • 22.4.7. Blister Configuration
      • 22.4.8. Drug Form
      • 22.4.9. Distribution Channel
      • 22.4.10. End-use Applications
    • 22.5. Argentina Pharmaceutical Blister Packaging Market
      • 22.5.1. Country Segmental Analysis
      • 22.5.2. Material Type
      • 22.5.3. Product Type
      • 22.5.4. Technology/Process Type
      • 22.5.5. Machine Type
      • 22.5.6. Pack Size
      • 22.5.7. Blister Configuration
      • 22.5.8. Drug Form
      • 22.5.9. Distribution Channel
      • 22.5.10. End-use Applications
    • 22.6. Rest of South America Pharmaceutical Blister Packaging Market
      • 22.6.1. Country Segmental Analysis
      • 22.6.2. Material Type
      • 22.6.3. Product Type
      • 22.6.4. Technology/Process Type
      • 22.6.5. Machine Type
      • 22.6.6. Pack Size
      • 22.6.7. Blister Configuration
      • 22.6.8. Drug Form
      • 22.6.9. Distribution Channel
      • 22.6.10. End-use Applications
  • 23. Key Players/ Company Profile
    • 23.1. ACG Worldwide
      • 23.1.1. Company Details/ Overview
      • 23.1.2. Company Financials
      • 23.1.3. Key Customers and Competitors
      • 23.1.4. Business/ Industry Portfolio
      • 23.1.5. Product Portfolio/ Specification Details
      • 23.1.6. Pricing Data
      • 23.1.7. Strategic Overview
      • 23.1.8. Recent Developments
    • 23.2. Algus Packaging Inc.
    • 23.3. Amcor plc
    • 23.4. Bausch + Ströbel
    • 23.5. Bilcare Limited
    • 23.6. Constantia Flexibles Group
    • 23.7. Gerresheimer AG
    • 23.8. Honeywell International Inc.
    • 23.9. IMA Group
    • 23.10. Klöckner Pentaplast
    • 23.11. Körber AG
    • 23.12. Marchesini Group S.p.A.
    • 23.13. Multivac Group
    • 23.14. Nipro Corporation
    • 23.15. Pharma Packaging Solutions
    • 23.16. Rollprint Packaging Products
    • 23.17. Romaco Group
    • 23.18. Schott AG
    • 23.19. Sonoco Products Company
    • 23.20. Tekni-Plex
    • 23.21. Uhlmann Pac-Systeme GmbH & Co. KG
    • 23.22. WestRock Company
    • 23.23. Other Key Players

Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography

Custom Market Research Services

We will customise the research for you, in case the report listed above does not meet your requirements.

Get 10% Free Customisation